What Prolia is, who it's for, and what the visit involves. It's an injection under the skin rather than an infusion, so the appointment is short. Written for patients and caregivers in Maryland.
Prolia (denosumab) is an osteoporosis medication given as a single injection under the skin, once every six months. It is not an infusion, so there is no IV line and no hours in a chair. The dose is 60 mg, injected into the upper arm, upper thigh, or abdomen by a healthcare provider. You take calcium and vitamin D daily alongside it. One thing to know before you start: Prolia is not a medication to stop on your own, because bone loss and spine fractures have been reported after people discontinue it without moving to something else. Springside administers Prolia in Columbia, Bowie, and Frederick, Maryland. Your prescriber keeps managing your bone health, and we handle the injection, the insurance authorization, and the paperwork.
Prolia is the brand name for denosumab, a medication given by injection under the skin to treat osteoporosis.
It is a monoclonal antibody, a lab-made protein built to lock onto one specific target. Prolia's target is a signaling protein called RANK ligand, usually shortened to RANKL.
A note on the name, because it causes real confusion. Denosumab is also sold as Xgeva at a different dose and on a different schedule for cancer-related bone problems. They are not interchangeable, and you should not receive both. If you are on Xgeva, say so.
Bone is torn down and rebuilt constantly. Osteoclasts break old bone away, osteoblasts lay new bone down. In osteoporosis the breaking-down side gets ahead, and what is left is thinner and easier to fracture.
RANKL is the message that tells osteoclasts to form and keep working. Prolia binds RANKL so that message does not arrive. Fewer osteoclasts get made, and less bone gets stripped away.
This is called antiresorptive treatment. It works on the losing side of the equation rather than adding new bone, and the aim is to slow the loss and lower your chance of a fracture.
Unlike the bisphosphonates, Prolia does not bind into bone and stay there. Its effect fades once you stop receiving it, which is the reason the six-month rhythm matters so much and the reason stopping is a decision to make with your prescriber rather than by drifting away from appointments.
Prolia is FDA-approved for:
Two situations change how this is handled. If your blood calcium is low, that has to be corrected before you are treated. And if you have advanced kidney disease, Prolia carries a boxed warning: severe drops in blood calcium have occurred, including cases that led to hospitalization and cases that were fatal. The label directs that treatment in those patients be supervised by a clinician with expertise in the bone and mineral problems that come with kidney disease, with blood work before you start and monitoring after.
Pregnancy has to be ruled out before a dose is given.
Your prescriber decides whether Prolia is appropriate. This page explains what the treatment involves once they have.
The dose is 60 mg as a single injection under the skin, once every six months. Two visits a year, and no starting series or half doses. Your first injection is the same as every one after it.
It is given by a healthcare provider, in the upper arm, the upper thigh, or the abdomen.
Alongside it you take calcium 1000 mg daily and at least 400 IU of vitamin D daily. That is part of the treatment rather than a suggestion, and it is what keeps your blood calcium where it should be.
Call us and come in. The label says a missed dose should be given as soon as you are available, and future injections are scheduled every six months from that one. A late dose is a problem to fix, not a reason to give up on the treatment.
This is the part of the Prolia label patients most need to hear. Multiple spine fractures have been reported after people stopped Prolia. The label says patients who discontinue it should be transitioned to another antiresorptive medication.
So if you are thinking about stopping, for cost, for side effects, for anything, have that conversation with your prescriber first so a plan is in place. Do not simply stop scheduling.
Exact doses and timings come from your prescriber. The schedule above is the standard pattern, not a substitute for the plan they write.
Each links to its condition guide, where you’ll find the other infusion medications used to treat it.
People often arrive braced for an infusion appointment and are surprised by how quick this is. There is no IV, no drip, and no bag to run through. Here is the shape of a typical visit.
Most of your visit is the conversation, not the injection. It is still a clinical appointment, so bring your insurance card, a current list of your medications and supplements, and any dental work you have coming up. You can drive yourself, and most people go straight back to their day.
In the trials in postmenopausal women, the reactions reported more often than with placebo were back pain, pain in an arm or leg, muscle and joint pain, higher cholesterol, and bladder infection. In men, back pain, joint pain, and cold symptoms came up most.
This is the warning that carries the most weight, especially if your kidneys are not working well. Take your calcium and vitamin D as directed, and call your prescriber about numbness or tingling around your mouth or in your fingers and toes, muscle cramps or spasms, or a change in how you are thinking or feeling. Do not wait for the next appointment.
Patients ask about the jaw more than anything else here, usually after reading something frightening online. Osteonecrosis of the jaw has been reported with Prolia, and the label recommends a dental examination before you start.
What to do with that: tell your dentist you are on Prolia, tell your prescriber about dental work you have planned, especially extractions or implants, and keep up your cleanings. Report jaw pain, gum swelling that will not settle, or a loose tooth. Do not stop treatment on your own because of something you read, given what the label says about stopping. Bring it to the prescriber who ordered it.
Tell us at check-in if you had a reaction to a previous injection, feel unwell that day, have an infection, have started a new medication, or have dental work coming up.
You can change where you receive your Prolia injections without changing your prescriber. Your endocrinologist, rheumatologist, or primary care physician continues to manage your bone health and writes the order. We give the injection and report back to them.
Many Maryland insurance plans now prefer, and some require, that non-urgent medications like this be given at an ambulatory center rather than a hospital outpatient department, often at meaningfully lower out-of-pocket cost. Coverage rules and prior-authorization requirements vary by plan, so we verify your benefits and handle the authorization before your first visit.
If you are switching to us mid-course, tell us the date of your last injection. Keeping the six-month rhythm intact matters more than where you get it.
Please include the following with your referral:
